Centre Hospitalier Universitaire Vaudois (CHUV), Yale University, National Cancer Center Hospital, University Hospital 12 de Octubre, Sarah Cannon Research Institute, Peter MacCallum Cancer Centre, Istanbul Medeniyet University, Hacettepe University, Dniprovsky State Medical University, Seoul National University - Department of Internal Medicine, Hospital Vall d’Hebron, Istituto Nazionale Tumori - IRCCS Fondazione G. Pascale, E.J. Zeyland Wielkopolska Center of Pulmonology and Thoracic Surgery, Matrahaza University, National Cancer Center Hospital East, German Centre for Lung Research - Lungen Clinic Grosshansdorf, Genentech, Inc. - San Francisco, Genentech, Inc. - San Francisco, Genentech, Inc. - San Francisco, Genentech, Inc. - San Francisco, Genentech, Inc. - San Francisco, Genentech, Inc. - San Francisco, Genentech, Inc. - San Francisco, Genentech, Inc. - San Francisco and Yonsei University - Yonsei Cancer Center

University of Turin, University of Turin, University of Turin, University of Turin, University of Turin, University of Turin, University of Turin, University of Turin, University of Turin, “Vito Fazzi” Hospital, Ospedale Giovanni Paolo II, Pederzoli Hospital-Peschiera del Garda, P.O.U. Villa Scassi Hospital - Medical Oncology, Mater Salutis Hospital AULSS9, “Scaligera” - Medical Oncology Unit, Humanitas Hospital Gradenigo, Ovidius University of Constanta, Renato Dulbecco University Hospital - Medical Oncology, Cardinal Massaia Hospital, Santo António University Hospital Center (CHUSA), University Hospital 12 de Octubre, Hospital Vall d’Hebron, University of Belgrade, Romanian Academy - Romanian Academy, University of Tirana, ASST Papa Giovanni XXIII, University of Florence, University of Athens, University Clinic of Respiratory and Allergic Diseases, San Giovanni di Dio Hospital,, University of Turin, University of Naples Federico II, University of Turin, University of Turin, University of Turin and University of Turin

WIN Consortium - Worldwide Innovative Network (WIN) Association, Groupe Hospitalier Saint-Joseph, École Normale Supérieure - PSL Research University - Institut Curie, Pfizer, Inc., AstraZeneca Pharmaceuticals, WIN Consortium - Worldwide Innovative Network (WIN) Association, WIN Consortium - Worldwide Innovative Network (WIN) Association, Avera Cancer Institute, WIN Consortium - Worldwide Innovative Network (WIN) Association, Hebrew University of Jerusalem - The Sharett Institute of Oncology, Chaim Sheba Medical Center, Chaim Sheba Medical Center, Fudan University - Department of Thoracic SurgeryFudan University - Shanghai Cancer Center, King Hussein Cancer Center (KHCC), Tokyo Medical and Dental University, University of Copenhagen - Rigshospitalet, I.M. Sechenov First Moscow State Medical University, Hospital Vall d’Hebron, Vall d’Hebron Institute of Oncology (VHIO)Hospital Vall d’Hebron, McGill University - Segal Cancer Center, McGill University - Segal Cancer Center, Tata Memorial Centre - Tata Memorial Hospital, Institut Mutualiste Montsouris, University of Claude Bernard Lyon 1 - Medical Oncology Department, École Normale Supérieure - PSL Research University - Institut Curie, Iuliu Hatieganu University of Medicine and Pharmacy, Ben-Gurion University of the NegevIuliu Hatieganu University of Medicine and Pharmacy, Ben-Gurion University of the NegevIuliu Hatieganu University of Medicine and Pharmacy, WIN Consortium - Worldwide Innovative Network (WIN) Association and WIN Consortium - Worldwide Innovative Network (WIN) Association

Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Institute of Oncology (VHIO), University of Montreal - Faculté de Pharmacie, Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Institute of Oncology (VHIO), Université de Montréal - Faculty of Pharmacy, University Health Network - Princess Margaret Bioinformatics and Computational Genomics Laboratory, University Health Network - Princess Margaret Bioinformatics and Computational Genomics Laboratory, Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Institute of Oncology (VHIO), Hospital Vall d’Hebron, Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Institute of Oncology (VHIO)Hospital Vall d’Hebron, Vall d’Hebron Institute of Oncology (VHIO) and Vall d’Hebron Institute of Oncology (VHIO)

affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, Hospital Vall d’Hebron, Hospital de la Santa Creu i Sant Pau - Medical Oncology Department, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN and Istituto Nazionale Tumori Regina Elena - Medical Oncology Department

Vall d’Hebron Institute of Oncology (VHIO), affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, Vall d’Hebron Institute of Oncology (VHIO), affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Institute of Oncology (VHIO)Hospital Vall d’Hebron, Hospital Vall d’Hebron, Vall d’Hebron Institute of Oncology (VHIO) and Vall d’Hebron Institute of Oncology (VHIO)